Who Paid My Doc
myChoice CDx
Device Tumor Dna Genetic Oncology Analysis
General payments
$296,806
Research payments
$165
Through program year 2022, $296,806 in general payments and $165 in research payments were reported against myChoice CDx (Tumor Dna Genetic Oncology Analysis).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | General | $88,828 | 420 |
| 2021 | General | $202,662 | 702 |
| 2021 | Research | $165 | 1 |
| 2020 | General | $5,316 | 6 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.
The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.
The top 5 of 34 states; each share is of general payments naming this product in 2022 where a state was reported.
Records
1,128 general · 1 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.